<DOC>
	<DOCNO>NCT01148745</DOCNO>
	<brief_summary>The purpose study evaluate time point transferrin saturation ( TSAT ) ferritin stabilization thirteen-treatment period follow ferumoxytol load , well determine point serum ferritin TSAT concentration check iron deficiency anemia ( IDA ) hemodialysis patient .</brief_summary>
	<brief_title>Iron Indices Intravenous Ferumoxytol : Time Steady State</brief_title>
	<detailed_description />
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Ferrosoferric Oxide</mesh_term>
	<criteria>Chronic hemodialysis subject receive dialysis treatment 90 day TSAT le equal 25 percent Serum ferritin less equal 200 nanograms/milliliter ( ng/mL ) ( Female ) Subjects willing use reliable contraception , undergone menopause ( chemical surgical ) Subjects able read write English Subjects sign consent Subjects enrol clinical trial within past 30 day Subjects receive IV iron within 4 week start study Serum ferritin great equal 1200 ng/dL Hemoglobin ( Hb ) less 10 grams/deciliter ( g/dL ) , great 13.5 g/dL Evidence iron overload Known hypersensitivity ferumoxytol component Anemia cause condition iron deficiency Subjects elective surgery schedule within next 3 month Subjects elective magnetic resonance procedure schedule study period Subjects hospitalize within past 30 day ( exclude vascular access care ) Subjects receive blood transfusion past 30 day Subjects transfusion dependent ( Female ) Subjects pregnant nursing Subjects know inflammatory condition may affect serum ferritin Subjects consider clinically unstable discretion Principal Investigator ( P.I . ) Subjects clinically unstable blood pressure ( BP ) systolic great 180 millimeter mercury ( mmHg ) and/or diastolic great 100 mmHg ( sit , predialysis ) Subjects life expectancy le 6 month Subjects refuse sign consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>